Snazy Health Products Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 21-12-2024
- Paid Up Capital ₹ 1.14 Cr
as on 21-12-2024
- Company Age 35 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.34 Cr
as on 21-12-2024
- Revenue %
(FY 2023)
- Profit 24.08%
(FY 2023)
- Ebitda -489.73%
(FY 2023)
- Net Worth -0.67%
(FY 2023)
- Total Assets -0.74%
(FY 2023)
About Snazy Health Products
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.14 Cr.
The company currently has active open charges totaling ₹8.34 Cr.
Amrinder Dhiman, Gajenderpal Dhiman, and Sahib Dhiman serve as directors at the Company.
- CIN/LLPIN
U15146PB1989PTC009859
- Company No.
009859
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Jalandhar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Snazy Health Products?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahib Dhiman  | Whole-Time Director | 01-Jun-2020 | Current |
| Amrinder Dhiman | Whole-Time Director | 15-Feb-2020 | Current |
| Gajenderpal Dhiman | Whole-Time Director | 01-Apr-2007 | Current |
Financial Performance of Snazy Health Products.
Snazy Health Products Pvt Ltd, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 24.08% increase in profit. The company's net worth dipped by a decrease of 0.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Snazy Health Products?
Unlock access to Snazy Health Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Dhiman Industry LimitedActive 13 years 9 months
Amrinder Dhiman, Gajenderpal Dhiman and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 01 Oct 2014 | ₹4.78 Cr | Open |
Bank Of India Creation Date: 21 Mar 2014 | ₹1.65 Cr | Open |
Bank Of India Creation Date: 10 Dec 2011 | ₹1.87 Cr | Open |
How Many Employees Work at Snazy Health Products?
Unlock and access historical data on people associated with Snazy Health Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Snazy Health Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Snazy Health Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
